A 52-year-old man with hypertension and benign prostatic hyperplasia is prescribed an alpha-1 blocker. After 2 weeks, he reports new-onset syncope and orthostatic dizziness. Which investigation is most appropriate to confirm the suspected adverse effect and guide dose adjustment?